Healthcare Equipment and Supplies
Company Overview of Ulthera, Inc.
Ulthera, Inc., a medical device company, develops and commercializes technologies for aesthetic and medical applications by using its therapeutic ultrasound platform technology. The company offers Ulthera System, an energy-based device for non-invasive aesthetic lift indication, which is used in Ultherapy, a procedure that lifts the skin above the eyebrows, on the neck, and under the chin. It provides its products through representatives and distributors worldwide. The company was founded in 2004 and is headquartered in Mesa, Arizona. As of July 29, 2014, Ulthera, Inc. operates as a subsidiary of Merz North America, Inc.
1840 South Stapley Drive
Mesa, AZ 85204
Founded in 2004
Key Executives for Ulthera, Inc.
Chief Executive Officer, President and Director
Vice President of Operations
Principal Accounting Officer and Controller
Compensation as of Fiscal Year 2015.
Ulthera, Inc. Key Developments
Ulthera Inc. Receives FDA Clearance for Ultherapy Décolletage Treatment
Jul 7 14
Ulthera Inc. announced that its ultrasound platform device, the Ulthera System, has received FDA clearance to non-invasively treat the chest to improve lines and wrinkles of the décolleté. The Ultherapy Décolletage Treatment utilizes the System's signature imaging and micro-focused ultrasound therapy capabilities and takes about 30 minutes to administer. The Treatment stimulates the natural formation of collagen and elastin in the skin's foundation to gradually smooth chest wrinkles. Results are visible after about three months. As with the FDA-cleared Ultherapy procedure for lifting the neck, eyebrow and under the chin, meaningful results are achieved in just one treatment, and there's no downtime or post-treatment care requirements. The Ultherapy Décolletage Treatment will be available in more than 1,500 physician practices across the United States, starting third quarter 2014. The Treatment is already cleared in more than 40 other countries worldwide and has been selectively available since 2012.
Ulthera Appoints Marshall Mohr to Board of Directors
Apr 16 14
Ulthera Inc. announced that Marshall Mohr has joined its board of directors. Mohr is currently the Senior Vice President and Chief Financial Officer at Intuitive Surgical. Mohr serves on the boards of directors of Plantronics Inc. and Pacific Biosciences of California Inc.
Ulthera System Receives Third FDA Clearance
Jan 30 14
Ulthera Inc. announced that its ultrasound platform device, the Ulthera System, has been cleared by the Food and Drug Administration (FDA) to visualize the dermal and subdermal layers of tissue during the non-invasive lifting treatment, Ultherapy. This marks the third FDA clearance the Ulthera System has received. The first two in September 2009 and October 2012, cleared the Ulthera System to non-invasively treat the face and neck with specific, first-and-only indications to lift skin on the neck, under the chin and above the brow.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|